Arvinas (ARVN) Current Leases (2019 - 2026)
Arvinas (ARVN) recorded quarterly Current Leases of $1.8 million in Q1 2026, up 5.88% quarter-over-quarter from $1.7 million in Q4 2025, and down 5.26% on a YoY basis from $1.9 million in Q1 2025.
Arvinas (ARVN) Current Leases (2019 - 2026) Analysis & Trends
Arvinas' Current Leases history runs 8 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Current Leases fell 5.26% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (down 5.26% YoY), while the FY2025 annual figure was $1.7 million, down 5.56% from the prior year.
- Current Leases was $1.8 million for Q1 2026 at Arvinas, up from $1.7 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.9 million in Q1 2023 to a low of $800000.0 in Q3 2024.
- Historically, Current Leases has averaged $1.7 million across 5 years, with a median of $1.8 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Current Leases tumbled 57.89% in 2024, then soared 112.5% in 2025.
- A 5-year view of Current Leases shows it stood at $1.8 million in 2022, then gained by 5.56% to $1.9 million in 2023, then slipped by 5.26% to $1.8 million in 2024, then declined by 5.56% to $1.7 million in 2025, then climbed by 5.88% to $1.8 million in 2026.
- The last three Current Leases figures came in at $1.8 million (Q1 2026), $1.7 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 1.70 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 1.90 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 1.90 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | 1.80 Mn |
| Jun 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 1.12 Mn |
| Jun 30, 2021 | 1.22 Mn |